Esperion Therapeutics
ESPR
ESPR
187 hedge funds and large institutions have $286M invested in Esperion Therapeutics in 2025 Q3 according to their latest regulatory filings, with 47 funds opening new positions, 56 increasing their positions, 37 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
4% more ownership
Funds ownership: 49.55% → 53.55% (+4%)
9% more call options, than puts
Call options by funds: $3.25M | Put options by funds: $2.99M
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
187
Holding in Top 10
1
Calls
$3.25M
Puts
$2.99M
Top Buyers
| 1 | +$6.36M | |
| 2 | +$5.8M | |
| 3 | +$5.8M | |
| 4 |
RA
Royce & Associates
New York
|
+$4.44M |
| 5 |
IHAM
Integral Health Asset Management
New York
|
+$2.9M |
Top Sellers
| 1 | -$6.34M | |
| 2 | -$5.4M | |
| 3 | -$2.95M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$2.17M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.54M |
